These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18472240)

  • 1. Assessment of breast cancer response to neoadjuvant chemotherapy: is volumetric MRI a reliable tool?
    Lorenzon M; Zuiani C; Londero V; Linda A; Furlan A; Bazzocchi M
    Eur J Radiol; 2009 Jul; 71(1):82-8. PubMed ID: 18472240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy.
    Takeda K; Kanao S; Okada T; Kataoka M; Ueno T; Toi M; Ishiguro H; Mikami Y; Togashi K
    Eur J Radiol; 2012 Oct; 81(10):2627-31. PubMed ID: 22221829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy.
    Demartini WB; Lehman CD; Peacock S; Russell MT
    Acad Radiol; 2005 Jul; 12(7):806-14. PubMed ID: 16039534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response analysis of non-hodgkin lymphoma using magnetic resonance imaging-based volumes.
    Rossi M; Dastidar P; Pertovaara H; Järvenpää R; Luukkaala T; Kellokumpu-Lehtinen PL; Rautakunnas S; Heinonen T; Soimakallio S; Eskola H
    J Comput Assist Tomogr; 2009; 33(3):466-74. PubMed ID: 19478645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?
    Heldahl MG; Lundgren S; Jensen LR; Gribbestad IS; Bathen TF
    J Magn Reson Imaging; 2011 Sep; 34(3):547-56. PubMed ID: 21761463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.
    Yu HJ; Chen JH; Mehta RS; Nalcioglu O; Su MY
    J Magn Reson Imaging; 2007 Sep; 26(3):615-23. PubMed ID: 17729334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
    Jensen LR; Garzon B; Heldahl MG; Bathen TF; Lundgren S; Gribbestad IS
    J Magn Reson Imaging; 2011 Nov; 34(5):1099-109. PubMed ID: 22002757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MR imaging of the breast before and after neoadjuvant treatment - enhancement characteristics and T 2 signal intensity of breast cancers and breast parenchyma].
    Siegmann KC; Müller KT; Vogel U; Krauss K; Claussen CD
    Rofo; 2010 Jun; 182(6):493-500. PubMed ID: 19953430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
    Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
    Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric breast density estimation from full-field digital mammograms.
    van Engeland S; Snoeren PR; Huisman H; Boetes C; Karssemeijer N
    IEEE Trans Med Imaging; 2006 Mar; 25(3):273-82. PubMed ID: 16524084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility and repeatability of volumetric measurements for olfactory bulb volumetry: which method is appropriate? An update using 3 Tesla MRI.
    Burmeister HP; Baltzer PA; Möslein C; Bitter T; Gudziol H; Dietzel M; Guntinas-Lichius O; Kaiser WA
    Acad Radiol; 2011 Jul; 18(7):842-9. PubMed ID: 21669350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional magnetic resonance observation of cartilage repair tissue (MOCART) score assessed with an isotropic three-dimensional true fast imaging with steady-state precession sequence at 3.0 Tesla.
    Welsch GH; Zak L; Mamisch TC; Resinger C; Marlovits S; Trattnig S
    Invest Radiol; 2009 Sep; 44(9):603-12. PubMed ID: 19692843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
    Johansen R; Jensen LR; Rydland J; Goa PE; Kvistad KA; Bathen TF; Axelson DE; Lundgren S; Gribbestad IS
    J Magn Reson Imaging; 2009 Jun; 29(6):1300-7. PubMed ID: 19472387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results.
    Loo CE; Teertstra HJ; Rodenhuis S; van de Vijver MJ; Hannemann J; Muller SH; Peeters MJ; Gilhuijs KG
    AJR Am J Roentgenol; 2008 Nov; 191(5):1331-8. PubMed ID: 18941065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
    Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
    Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
    Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
    J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
    Wu LM; Hu JN; Gu HY; Hua J; Chen J; Xu JR
    Breast Cancer Res Treat; 2012 Aug; 135(1):17-28. PubMed ID: 22476850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal MRI volumetry at 3 Tesla: reliability and practical guidance.
    Jeukens CR; Vlooswijk MC; Majoie HJ; de Krom MC; Aldenkamp AP; Hofman PA; Jansen JF; Backes WH
    Invest Radiol; 2009 Sep; 44(9):509-17. PubMed ID: 19692839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.